Advanced Search

    Technical Analysis for CALC - Calcimedica Inc

    Grade Last Price % Change Price Change
    A 5.2750 0.48% 0.0250
    CALC closed up 0.48 percent on Friday, June 9, 2023, on 74 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong N/A N/A Up
    Historical CALC trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing High Bullish 0.00%
    180 Bullish Setup Bullish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Shooting Star Candlestick Bearish 0.48%
    Lizard Bearish Bearish Day Trade Setup 0.48%
    NR7 Range Contraction 0.48%
    NR7-2 Range Contraction 0.48%
    Narrow Range Bar Range Contraction 0.48%
    Older End-of-Day Signals for CALC ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Down 3% about 12 hours ago
    Down 1% about 12 hours ago
    Down 2% about 12 hours ago
    Lizard Bearish Entry about 12 hours ago
    Shooting Star Candlestick Entry about 12 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    CALC Chart by TradingView
    Basic chart:

    Profile

    CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.
    Classification
    Keywords: Medicine Health Biotechnology Medical Specialties Inflammatory Diseases Abdominal Pain Medical Emergencies Pancreas Acute Kidney Injury Pancreatitis

    Is CALC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.4
    52 Week Low 2.06
    Average Volume 8,148
    200-Day Moving Average 0.0000
    50-Day Moving Average 0.0000
    20-Day Moving Average 3.7225
    10-Day Moving Average 4.5845
    Average True Range 0.4237
    RSI (14) 73.33
    ADX 27.7
    +DI 39.9298
    -DI 19.5484
    Chandelier Exit (Long, 3 ATRs) 4.1289
    Chandelier Exit (Short, 3 ATRs) 3.7711
    Upper Bollinger Bands 5.7566
    Lower Bollinger Band 1.6884
    Percent B (%b) 0.88
    BandWidth 109.2868
    MACD Line 0.5180
    MACD Signal Line 0.2860
    MACD Histogram 0.232
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.7850
    Resistance 3 (R3) 5.7533 5.5517 5.7000
    Resistance 2 (R2) 5.5517 5.4218 5.5675 5.6716
    Resistance 1 (R1) 5.4133 5.3415 5.4825 5.4450 5.6433
    Pivot Point 5.2117 5.2117 5.2463 5.2275 5.2117
    Support 1 (S1) 5.0733 5.0818 5.1425 5.1050 4.9067
    Support 2 (S2) 4.8717 5.0015 4.8875 4.8784
    Support 3 (S3) 4.7333 4.8717 4.8500
    Support 4 (S4) 4.7650